Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
77 Cards in this Set
- Front
- Back
Cholesterol ring structure
|
can not be broken down by humans
|
|
Cholesterol can not be catabolized to
|
CO2
|
|
Cholesterol is a component of
|
membranes
|
|
Rate limiting step of drug therapy
|
HMG-CoA reductase
|
|
Cholesterol is starting material for
|
Bile, Vitamin D synthesis, Steroids
|
|
Cholesterol ester levels do not
|
Alter the rate of cholesterol synthesis
|
|
Proteolysis of HMG CoA reductase increases as
|
sterol levels rise
|
|
high insulin:glucagon then HMG coA reductase is
|
dephosphorylated and active, signals ATP and acetyl coA available for chol synthesis
|
|
Statin
|
inhibits HMG coA reductase
|
|
Cholesterol is esterified/de-esterified on lipoproteins by
|
LCAT or ACAT- esterifies cholesterol
|
|
Cholesterol stored in cell for use later as
|
cholesterol ester
|
|
Esterified cholesterol can be trasnferred
|
from HDL to IDL
|
|
Bil acid synthesis takes place in
|
hepatocytes
|
|
Bile acid synthesis starts with
|
cholesterol, ATP and NADPH
|
|
Bile acid synthesis regulation step
|
7 alpha-hydroxycholesterol production from cholesterol is feedback inhibited by high bile salt level
|
|
Products of bile acid synthesis
|
primary bile salts: cholic acid and chenocholic acid
|
|
Four different conjugated primary bile salts
|
taurocholic, glycocholic, taurochenocholic and glycochenocholic acid
|
|
Conjugation
|
increases bile acid solubility allowing bile salts to be detergents
|
|
Four secondary bile salts
|
deoxycholic acid, lithocholic acid, deocychenocholic acid, and lithochenocholic acids made by bacterial action on 4 conjugate primary bile salts once in intestine
|
|
Serum tryglyceride levels are proprotional to VLDL levels when
|
fasting
|
|
Chylomicrons
|
transport dietary lipids
|
|
What state do chylomicrons occur in?
|
fed
|
|
Are chylomicrons synthesized by liver?
|
No only lipoprotein that isnt, making them the lightest (float)
|
|
What do chylomicrons form
|
Nascient chylomicrons by picking up dietary triglycerides and cholesterol
|
|
HDL transfer what to nascent chylomicrons
|
Apo E for hepatic receptors and Apo C11 activates liporprotein lipase
|
|
Mature chylomicrons transport to adipose and skeletal muscle cells
|
LPL ocnvert chylomicron trigylcerides to FFA and glycerol
|
|
Apo C on chylomicrons activates
|
LPL
|
|
Insulin also activates LPL by
|
inducing its synthesis
|
|
Skeletal muscle prefers
|
chylomicron triglycerides, lower Km for it than adipose lipoprotein lipase
|
|
Chylomicron remnants
|
enter liver and broken into component molecules
|
|
Dietary cholesterol
|
carried from intestine to liver on chylomicron remnants
|
|
Dietary cholesterol results in down regulation of
|
HMGCoA synthesis and increases proteolysis of it
|
|
Dietary cholesterol unused goes to
|
VLDLs + cholesterol made in liver
|
|
VLDLs high
|
tyrglyceride concentration makin them least dence of liver lipoproteins
|
|
VLDL are made in
|
liver
|
|
VLDL deliver triglycerides to
|
skeletal muscle and adipose tissue
|
|
Donation of Apo C to VLDL for
|
Lipoprotein lipase allows VLDL to break into fatty acids and glycerol
|
|
VLDL become IDL when ____ are removed
|
triglycerides
|
|
2 fates of IDL
|
to become LDL or return to the liver
|
|
Cholesterol made in liver or delivered to liver by chylomicron remnants leave with
|
VLDL exported out the liver
|
|
Liporprotein lipase action on VLDL causes them to become
|
more dense density more like an IDL
|
|
IDL may return to
|
liver
|
|
IDL are recognized by
|
LDL receptors, endocytosed and degraded in liver
|
|
Triglyclerides removed from IDL
|
increase their density and help them become LDLs
|
|
Triglyceride removal occurs in and uses
|
hepatic sinusoids and uses hepatic triglyceride lipase
|
|
Cholesterol esters are transferred from HDL to IDL
|
As the IDL becomes LDL
|
|
Amount of IDL entering liver vs becoming LDL
|
depends on hepatic LDL receptors which depends on amount of cholesterol in liver
|
|
LDL deliver cholesterol to
|
extra-hepatic cells
|
|
acetyl coa comes from
|
glucose, fatty acids, amino acids
|
|
Almost all bile salts are
|
reabsorbed
|
|
Drugs decreasing bile salt reabsoprtion increase
|
cholesterol excretion
|
|
Specific uptake of LDL by extra-hepatic cells occurs by
|
LDL receptors on surface of cell
|
|
cholesterol ester (free cholesterol) leads to
|
down regulation of genes for LDL receptor synthesis and HMG coA synthesis
|
|
LRP proteins dont depends on
|
amount of cholesterol cellular levels
|
|
LRP help decrease
|
serum levels of lipoproteins
|
|
High hepatic cholesterol levels prevents IDL
|
return to liver
|
|
Excess LDL in serum can be oxidized by
|
reactive oxygen species
|
|
Antioxidants can decrease
|
oxidative species
|
|
genetically defective LDL receptors occurs=
|
high serum LDL levels early in life
|
|
HMGcoA is still expressed in LDL defected receptors
|
Can't get into the cell so cholesterol levels still appear low
|
|
with defected LDL receptors extra-hepatic cholesterol synthesis is
|
turned on
|
|
Specific uptake of LDL by extra-hepatic cells occurs by
|
LDL receptors on surface of cell
|
|
cholesterol ester (free cholesterol) leads to
|
down regulation of genes for LDL receptor synthesis and HMG coA synthesis
|
|
LRP proteins dont depends on
|
amount of cholesterol cellular levels
|
|
LRP help decrease
|
serum levels of lipoproteins
|
|
High hepatic cholesterol levels prevents IDL
|
return to liver
|
|
Excess LDL in serum can be oxidized by
|
reactive oxygen species
|
|
Antioxidants can decrease
|
oxidative species
|
|
genetically defective LDL receptors occurs=
|
high serum LDL levels early in life
|
|
HMGcoA is still expressed in LDL defected receptors
|
Can't get into the cell so cholesterol levels still appear low
|
|
with defected LDL receptors extra-hepatic cholesterol synthesis is
|
turned on
|
|
Increase in VLDL
|
increase in IDL and LDL
|
|
HDL pick up
|
cholesterol from degrading membranes and esterify it w LCAT
|
|
most hepatic uptake of HDL occurs via
|
non-specific scavenger receptor SR-B1
|
|
SR-B1 do not down regulate with
|
high heaptic cholesterol levels
|
|
limiting dietary cholesterol, trans fatty acids may lower
|
LDLs
|
|
Lp(a) found elevated
|
post-MI
|